Skip to main content
NOVAVAX INC logo

NOVAVAX INC — Investor Relations & Filings

Ticker · NVAX ISIN · US6700024010 LEI · 529900J4GJHPEPQ23205 US Manufacturing
Filings indexed 1,095 across all filing types
Latest filing 2015-03-09 Director's Dealing
Country US United States of America
Listing US NVAX

Novavax Inc. is a biotechnology company that develops and commercializes vaccines to prevent serious infectious diseases. The company utilizes a proprietary, protein-based vaccine technology platform, which includes its novel Matrix-M™ adjuvant, to create its vaccine candidates. Its primary commercial product is a protein-based COVID-19 vaccine, Nuvaxovid™. Novavax's research and development pipeline is focused on addressing significant health needs, including influenza and a combination COVID-19-influenza vaccine. The company's strategy emphasizes advancing its pipeline assets and establishing strategic partnerships to maximize the global health impact of its technology.

Recent filings

Filing Released Lang Actions
FORM 4 SUBMISSION
Director's Dealing
2015-03-09 English
FORM 4 SUBMISSION
Director's Dealing
2015-03-09 English
FORM 4 SUBMISSION
Director's Dealing
2015-03-09 English
FORM 4 SUBMISSION
Director's Dealing
2015-03-09 English
CURRENT REPORT
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report. It announces the company's financial results for the quarter ended December 31, 2014, and includes a press release as an exhibit. The document itself is short (3483 characters) and primarily serves to announce the earnings release rather than containing detailed financial statements or analysis. The text explicitly states that the press release is attached as an exhibit and that the information is not deemed "filed" for certain regulatory purposes. This aligns with the characteristics of an Earnings Release (ER) announcement within an 8-K filing. Therefore, the document is best classified as an Earnings Release (ER).
2015-02-27 English
FORM 10-K
Annual Report FY 2014
2015-02-26 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.